China NMPA Product Recall - ECG leads

GE Healthcare Finland Oy initiated a Class II voluntary recall for its ECG leads due to a potential short-circuit issue. This problem can arise during defibrillation when removing three-lead integrated ECG leads, posing a safety risk; however, no associated injuries have been reported. The recall was formally reported to China's National Medical Products Administration (NMPA) on February 25, 2019, with the NMPA publishing the information on March 8, 2019. Operating under the NMPA's regulatory oversight, GE Healthcare's required actions include advising customers to immediately cease using and isolate affected integrated ECG leads. The company has also committed to implementing corrective measures for all affected systems. It is noteworthy that while this incident was reported to Chinese authorities, the specific batches of affected products were not distributed or sold in China, with the USA identified as an affected region. This action reflects GE Healthcare's dedication to global product safety standards.